Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | viral clearance | |||
| discontinuation of ACEI/ARB | - | - | 0.97 [0.38; 2.50], 1 RCT, I2=0% inconclusive result | - | ||
| angiotensin converting enzyme inhibitors (ACEIs) | 0 | - | - | - | - | |
| angiotensin receptor blockers (ARBs) | 0 | - | - | - | - | |
| angiotensin-(1-7) | 0 | - | - | - | - | |
| continuation of ACEI/ARB | 0 | - | - | - | - | |
| RAS blocker withdrawal | 0 | - | - | - | - | |
| rhACE2 | 0 | - | - | - | - | |